IQ Capital logo

IQ Capital

Venture CapitalPrivate Equity·London, UK·~£1B AUM across five funds; latest $400M raise (Fund V, 2023)

Founded in 2005, IQ Capital is a leading European deep tech venture capital firm based in Cambridge and London. Its general partners, Kerry Baldwin, Max Bautin, Simon Hirtzel, and Ed Stacey, have worked together for over 20 years. The firm leads rounds from pre-Seed to Series A and follows on via dedicated growth funds with up to £30m per company. Since inception it has partnered with over 200 deep tech founders, attracting $1.4 billion in follow-on capital to its portfolio. Notable investments include Thought Machine (core banking unicorn backed from Seed), Speechmatics, and Nyobolt, with exits to Apple, Meta, Google, Siemens, Qualcomm, and Oracle.

Focus Areas

AI/AutomationComputing/SemiconductorsHealth/BioAdvanced Engineering/EnergySecurity/Resilience

Portfolio

15 companies in our directory

A

AccelerComm

Hiring
Series B

Provides high-performance physical layer IP for 5G and satellite (non-terrestrial) networks to optimize power, latency and resilience.

ToffeeX logo

ToffeeX

Series A

Physics-driven generative design software that uses simulation to rapidly produce optimal thermo-fluid component geometries for manufacturing.

QuadSAT logo

QuadSAT

Series A

Delivers UAV-based RF measurement and antenna testing systems for the satellite, defense, and wireless communication sectors.

Porotech logo

Porotech

Series B

Develops porous GaN (gallium nitride) materials and micro-LED technologies (PoroGaN® / DPT®) for high-performance, energy-efficient semiconductor devices.

Paragraf logo

Paragraf

Series C

Scalable graphene deposition technology to lay single-atom-thick 2D materials on semiconductor substrates, for use in sensors, electronics, and energy harvesting.

OSS logo

OSS

Series A

Oxford Space Systems develops deployable satellite antennas that are smaller, lighter, and more cost-effective than traditional designs, aiming to become the global leader in space antenna technology.

Nyobolt logo

Nyobolt

Series C

Builds ultra-fast charging, high-power batteries using niobium-based anode materials, targeting data centres, robotics, EVs and other high-duty applications.

Mytos logo

Mytos

Hiring
Series A

Mytos automates the production of stem cell-derived regenerative medicines to make life-saving therapies for conditions like Parkinson's and spinal cord injury accessible and affordable to millions of patients.

Molyon logo

Molyon

Pre-seed

Molyon develops long-life lithium-sulphur batteries that deliver twice the energy density of current lithium-ion batteries, providing next-generation energy storage solutions.

IONATE logo

IONATE

Hiring
Series A

Ionate develops smart transformer hardware and AI-powered software to modernise century-old power infrastructure, creating adaptable and efficient energy systems for data centres and electricity grids.

FocalPoint logo

FocalPoint

Hiring
Series C

FocalPoint develops S-GNSS software using patented Supercorrelation technology to enhance GPS positioning accuracy for automotive, smartphones, and wearables in challenging environments like urban canyons and under foliage.

F

Flink

Pre-seed

Flink develops FlinkAI software that transforms industrial robots into plug-and-play systems for material handling, enabling them to pack, unload, and sort any material within minutes without altering existing facilities.

Cambridge GaN Devices logo

Cambridge GaN Devices

Hiring
Series C

Cambridge GaN Devices develops ICeGaN gallium nitride power transistors that operate like MOSFETs with higher efficiency and switching frequencies, enabling up to 50% energy savings in applications from data centres to electric vehicles.

Aibuild logo

Aibuild

Hiring
3D Printing·Series A

Aibuild develops AI-powered software that automates and optimises industrial-scale additive manufacturing, enabling fully automated toolpath generation and real-time process control across polymer, metal, and concrete 3D printing systems.

Pictura Bio logo

Pictura Bio

Biotech

Pictura Bio develops a one-minute pathogen detection platform using computer vision and fluorescence microscopy, enabling point-of-care infectious disease diagnostics with a single universal reagent for all tests.